Inotek Pharmaceuticals Corp Stock Nasdaq
Equities
US45780V1026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Sales 2024 * | 29.54M 0 | Sales 2025 * | 186M 0 | Capitalization | 2.14B 0 |
---|---|---|---|---|---|
Net income 2024 * | -262M - | Net income 2025 * | -217M - | EV / Sales 2024 * | 66.9 x |
Net cash position 2024 * | 163M 0 | Net cash position 2025 * | 59.29M 0 | EV / Sales 2025 * | 11.2 x |
P/E ratio 2024 * |
-8.89
x | P/E ratio 2025 * |
-12.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.43% |
Latest transcript on Inotek Pharmaceuticals Corp
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |